Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Ageing Research Reviews,
Journal Year:
2025,
Volume and Issue:
unknown, P. 102689 - 102689
Published: Feb. 1, 2025
Language: Английский
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Pharmacological Reviews,
Journal Year:
2024,
Volume and Issue:
76(6), P. 978 - 1008
Published: Sept. 20, 2024
Both
preclinical
and
clinical
studies
implicate
functional
impairments
of
several
neuroactive
metabolites
the
kynurenine
pathway
(KP),
major
degradative
cascade
essential
amino
acid
tryptophan
in
mammals,
pathophysiology
neurologic
psychiatric
diseases.
A
number
KP
enzymes,
such
as
2,3-dioxygenase
(TDO2),
indoleamine
2,3-dioxygenases
(IDO1
IDO2),
aminotransferases
(KATs),
3-monooxygenase
(KMO),
3-hydroxyanthranilic
oxygenase
(3-HAO),
quinolinic
phosphoribosyltransferase
(QPRT),
control
brain
metabolism
health
disease
are
therefore
increasingly
considered
to
be
promising
targets
for
treatment
disorders
nervous
system.
Understanding
distribution,
cellular
expression,
regulation
enzymes
is
critical
conceptualization
implementation
successful
therapeutic
strategies.
SIGNIFICANCE
STATEMENT:
Studies
have
implicated
Key
regulate
both
disease,
making
them
treating
these
disorders.
Therefore,
understanding
developing
effective
This
review
endeavors
describe
processes
detail.
Language: Английский
Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2244 - 2244
Published: July 12, 2024
Aging
is
the
most
prominent
risk
factor
for
neurodegeneration
occurrence.
The
common
neurodegenerative
diseases
(NDs),
Alzheimer’s
(AD)
and
Parkinson’s
(PD)
diseases,
are
characterized
by
incidence
of
proteinopathy,
abnormal
activation
glial
cells,
oxidative
stress,
neuroinflammation,
impaired
autophagy
cellular
senescence
excessive
patient’s
age.
Moreover,
mitochondrial
disfunction,
epigenetic
alterations
neurogenesis
inhibition,
together
with
increased
blood–brain
barrier
permeability
gut
dysbiosis,
have
been
linked
to
ND
pathogenesis.
Since
NDs
still
lack
curative
treatment,
recent
research
has
sought
therapeutic
options
in
restoring
microbiota
supplementing
probiotic
bacteria-derived
metabolites
beneficial
action
host—so
called
postbiotics.
current
review
focuses
on
literature
explaining
mechanisms
involved
pathogenesis
addressing
impact
that
postbiotics
as
a
whole
mixture
particular
metabolites,
such
short-chain
fatty
acids
(SCFAs),
lactate,
polyamines,
polyphenols,
tryptophan
exopolysaccharides
bacterial
extracellular
vesicles,
ageing-associated
processes
underlying
also
discusses
issue
implementing
into
prophylaxis
therapy,
depicting
them
compounds
senescence-triggered
dysfunctions
worth
translating
from
bench
pharmaceutical
market
response
“silver
consumers”
demands.
Language: Английский
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 9082 - 9082
Published: Aug. 21, 2024
Kynurenic
acid
(KYNA)
is
an
antioxidant
degradation
product
of
tryptophan
that
has
been
shown
to
have
a
variety
cytoprotective,
neuroprotective
and
neuronal
signalling
properties.
However,
mammalian
transporters
receptors
display
micromolar
binding
constants;
these
are
consistent
with
its
typically
tissue
concentrations
but
far
above
serum/plasma
concentration
(normally
tens
nanomolar),
suggesting
large
gaps
in
our
knowledge
transport
mechanisms
action,
the
main
influx
characterized
date
equilibrative,
not
concentrative.
In
addition,
it
substrate
known
anion
efflux
pump
(ABCC4),
whose
vivo
activity
largely
unknown.
Exogeneous
addition
L-tryptophan
or
L-kynurenine
leads
production
KYNA
also
many
other
co-metabolites
(including
some
such
as
3-hydroxy-L-kynurenine
quinolinic
may
be
toxic).
With
exception
chestnut
honey,
exists
at
relatively
low
levels
natural
foodstuffs.
bioavailability
reasonable,
terminal
element
irreversible
reaction
most
pathways,
might
added
exogenously
without
disturbing
upstream
metabolism
significantly.
Many
examples,
which
we
review,
show
valuable
bioactivity.
Given
above,
review
potential
utility
nutraceutical,
finding
significantly
worthy
further
study
development.
Language: Английский
Gut microbial metabolism in Alzheimer's disease and related dementias
Jea Woo Kang,
No information about this author
Vaibhav BV Vemuganti,
No information about this author
Jessamine F. Kuehn
No information about this author
et al.
Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
21(6), P. e00470 - e00470
Published: Oct. 1, 2024
Multiple
studies
over
the
last
decade
have
established
that
Alzheimer's
disease
and
related
dementias
(ADRD)
are
associated
with
changes
in
gut
microbiome.
These
alterations
organismal
composition
result
abundances
of
functions
encoded
by
microbial
community,
including
metabolic
capabilities,
which
likely
impact
host
mechanisms.
Gut
microbes
access
dietary
components
other
molecules
made
produce
metabolites
can
enter
circulation
cross
blood-brain
barrier
(BBB).
In
recent
years,
several
been
or
shown
to
influence
pathways
relevant
ADRD
pathology.
include
short
chain
fatty
acids,
secondary
bile
tryptophan
derivatives
(such
as
kynurenine,
serotonin,
tryptamine,
indoles),
trimethylamine/trimethylamine
N-oxide.
Notably,
some
these
BBB
various
effects
on
brain,
modulating
release
neurotransmitters
neuronal
function,
inducing
oxidative
stress
inflammation,
impacting
synaptic
function.
Microbial
also
central
nervous
system
through
immune,
enteroendocrine,
enteric
pathways,
perturbations
turn
function
peripheral
immune
responses,
well
integrity,
homeostasis
neurogenesis,
glial
cell
maturation
activation.
This
review
examines
evidence
supporting
notion
is
influenced
microbiota
its
metabolites.
The
potential
therapeutic
advantages
for
preventing
treating
discussed,
highlighting
their
role
developing
new
treatments.
Language: Английский
Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
Masaru Tanaka,
No information about this author
Ágnes Szabó,
No information about this author
László Vécsei
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12767 - 12767
Published: Nov. 27, 2024
The
tryptophan-kynurenine
(KYN)
pathway
has
long
been
recognized
for
its
essential
role
in
generating
metabolites
that
influence
various
physiological
processes.
Traditionally,
these
have
categorized
into
distinct,
often
opposing
groups,
such
as
pro-oxidant
versus
antioxidant,
excitotoxic/neurotoxic
neuroprotective.
This
dichotomous
framework
shaped
much
of
the
research
on
conditions
like
neurodegenerative
and
neuropsychiatric
disorders,
well
cancer,
where
metabolic
imbalances
are
a
key
feature.
effects
significantly
influenced
by
factors,
including
concentration
particular
cellular
milieu
which
they
generated.
A
molecule
acts
neuroprotective
at
low
concentrations
may
exhibit
neurotoxic
elevated
levels.
oxidative
equilibrium
surrounding
environment
can
alter
function
KYN
from
an
antioxidant
to
pro-oxidant.
narrative
review
offers
comprehensive
examination
analysis
contemporary
understanding
metabolites,
emphasizing
their
multifaceted
biological
functions
relevance
numerous
pathological
underscores
pressing
necessity
paradigm
shift
comprehension
metabolism.
Understanding
context-dependent
roles
is
vital
novel
therapies
Alzheimer's
disease,
multiple
sclerosis,
cancer.
Comprehensive
modulation,
balancing
inflammatory
signals
enzyme
regulation,
promising
avenues
targeted,
effective
treatments.
Language: Английский
Role of Kynurenine and Its Derivatives in Liver Diseases: Recent Advances and Future Clinical Perspectives
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 968 - 968
Published: Jan. 24, 2025
Liver
health
is
integral
to
overall
human
well-being
and
the
pathogenesis
of
various
diseases.
In
recent
years,
kynurenine
its
derivatives
have
gradually
been
recognized
for
their
involvement
in
pathophysiological
processes,
especially
regulation
liver
diseases,
such
as
acute
injury,
non-alcoholic
fatty
disease,
cirrhosis,
cancer.
Kynurenine
are
derived
from
tryptophan,
which
broken
down
by
enzymes
indoleamine
2,3-dioxygenase
(IDO)
tryptophan
(TDO),
converting
essential
amino
acid
into
(KYN)
other
downstream
metabolites,
kynurenic
(KYNA),
3-hydroxykynurenine
(3-HK),
xanthurenic
(XA),
quinolinic
(QA).
can
promote
activity
transcription
factor
aryl
hydrocarbon
receptor
(AhR),
suppress
T
cell
immune
modulation,
inhibit
activation
inflammatory
signaling
pathways,
NF-κB
anti-inflammatory
effects,
hepatic
stellate
cells
slow
fibrosis
progression.
Additionally,
metabolites
influence
progression
diseases
modulating
gut
microbiota.
Therefore,
this
review,
we
summarize
explore
mechanisms
regulate
help
develop
new
diagnostic
or
prognostic
biomarkers
effective
therapies
targeting
pathway
disease
treatment.
Language: Английский
Systematic Insights into the Relationship between the Microbiota–Gut–Brain Axis and Stroke with the Focus on Tryptophan Metabolism
Xinyu Shen,
No information about this author
Xiaoqin Mu
No information about this author
Metabolites,
Journal Year:
2024,
Volume and Issue:
14(8), P. 399 - 399
Published: July 24, 2024
Stroke,
as
a
serious
cerebral
vascular
disease
with
high
incidence
and
rates
of
disability
mortality,
has
limited
therapeutic
options
due
to
the
narrow
time
window.
Compelling
evidence
highlighted
significance
gut
microbiota
gut-brain
axis
critical
regulatory
factors
affecting
stroke.
Along
microbiota-gut-brain
axis,
tryptophan
metabolism
further
acquires
increasing
attention
for
its
intimate
association
central
nervous
system
diseases.
For
purpose
exploring
potential
role
in
stroke
providing
systematic
insights
into
intricate
connection
pathological
procedure
stroke,
this
review
first
summarized
practical
relationship
between
by
compiling
latest
case-control
research.
Then,
well
interaction
were
comprehensively
elucidated
on
basis
basic
anatomical
structure
physiological
function.
Based
crosstalk
microbiota-gut-brain,
we
focused
from
three
major
metabolic
pathways,
namely,
kynurenine
pathway,
serotonin
microbial
within
axis.
Moreover,
effects
appreciated
elaborated
here,
which
is
scarcely
found
other
reviews.
Hopefully,
illustration
mechanisms
pathways
along
will
inspire
more
translational
research
perspectives,
paid
promising
pharmaceutical
target
order
reduce
risk
mitigate
progression,
ameliorate
prognosis.
Language: Английский